表紙
市場調査レポート

米国の特殊末梢血管製品市場:アテローム切除製品、バルーンカテーテル、慢性完全閉塞装置、塞栓保護装置

The U.S. Market for Specialty Peripheral Vascular Products in 2015: Atherectomy Products, Balloon Catheters, Chronic Total Occlusion Devices, and Embolic Protection Devices

発行 Life Science Intelligence, Inc. 商品コード 321888
出版日 ページ情報 英文 72 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=105.42円で換算しております。
Back to Top
米国の特殊末梢血管製品市場:アテローム切除製品、バルーンカテーテル、慢性完全閉塞装置、塞栓保護装置 The U.S. Market for Specialty Peripheral Vascular Products in 2015: Atherectomy Products, Balloon Catheters, Chronic Total Occlusion Devices, and Embolic Protection Devices
出版日: 2015年01月01日 ページ情報: 英文 72 Pages
概要

米国のアテローム切除製品、慢性完全閉塞装置、バルーンカテーテル、塞栓保護装置市場は2013年に8億3,600万米ドルとなりました。末梢動脈疾患治療の介入的方法の効果を向上させるための臨床での取り組みや技術進歩、薬剤コーティングバルーンなどの新規製品の影響などで、同市場は今後もさらに発展するものとみられています。

当レポートでは、米国の特殊末梢血管製品市場について調査し、市場の概要と新規技術の導入動向、参入企業の競合動向とプロファイルなどをまとめています。

第1章 エグゼクティブサマリー

第2章 概要

  • 循環器系
  • 血管の解剖と生理学
    • 末梢動脈
    • 冠状動脈
    • 頭部および頸部の動脈
  • 維管束組織と構造
  • 末梢血管疾患
  • 地域別の罹患率
    • 米国
    • 欧州
    • アジア太平洋地域その他

第3章 特殊末梢血管製品

  • アテローム切除技術
  • バルーンカテーテル
  • 慢性完全閉塞装置
  • 塞栓保護システム

第4章 処置予測と市場分析

  • アテローム切除技術
  • バルーンカテーテル
  • 慢性完全閉塞装置
  • 塞栓保護システム
  • 競合分析

第5章 企業プロファイル

  • Abbott Vascular (Abbott)
  • Bard Peripheral Vascular (C.R. Bard)
  • Boston Scientific
  • Cook Medical (Cook Group)
  • Cordis Corporation (Johnson & Johnson)
  • Covidien
  • Medtronic
  • W.L. Gore and Associates
目次

Atherectomy products, chronic total occlusion devices, balloon catheters, and embolic protection devices accounted for $836 million in U.S. sales during 2013. As discussed in Life Science Intelligence's new report, strong growth is expected in the U.S. market in coming years due to clinical efforts to improve the effectiveness of interventional methods for treating peripheral artery disease (PAD); attempts to refine techniques; and the impact of new products such as drug-coated balloons (DCBs), the first of which became commercially available in October 2014. This report examines the forces affecting the U.S. market for these technologies from 2012-2019 and covers key issues, such as:

  • Quantitative factors including units, pricing, and product sales;
  • The timing and market introduction of important new technologies;
  • Procedure volumes as well as other key infrastructure and market metrics; and
  • The competitive landscape.

Table of Contents

1. EXECUTIVE SUMMARY

  • 1.1. The U.S. Market by Product Type
  • 1.2. Competitive Analysis
  • Exhibit 1-1: Specialty Peripheral Vascular Procedures in the U.S. from 2012-2019
  • Exhibit 1-2: The U.S. Market Forecast for Atherectomy Products, Balloon Catheters, Chronic Total Occlusion Devices, and Embolic Protection Devices from 2012-2019
  • Exhibit 1-3: U.S. Supplier Shares in 2012 and 2013

2. OVERVIEW

  • 2.1. The Circulatory System
  • 2.2. Vascular Anatomy and Physiology
    • 2.2.1. Peripheral Arteries
    • 2.2.2. Coronary Arteries
    • 2.2.3. Arteries of the Head and Neck
  • 2.3. Vessel Tissues and Structures
  • 2.4. Peripheral Vascular Disease
  • 2.5. Prevalence of PAD by Region
    • 2.5.1. The United States
    • 2.5.2. Europe
    • 2.5.3. Asia-Pacific and the Rest of the World
  • Exhibit 2-1: Overview of the Circulatory System
  • Exhibit 2-2: Major Arteries in the Cardiovascular System
  • Exhibit 2-3: Types and Functions of the Blood Vessels
  • Exhibit 2-4: Peripheral Arteries and Arteries of the Lower Extremity
  • Exhibit 2-5: Arteries of the Hand, Including the Radial Artery
  • Exhibit 2-6: Arteries of the Head and Neck
  • Exhibit 2-7: Anatomy of the Arteries and Veins
  • Exhibit 2-8: Prevalence of Peripheral Artery Disease in the U.S.
  • Exhibit 2-9: Prevalence of Peripheral Artery Disease in Europe
  • Exhibit 2-10: Prevalence of Peripheral Artery Disease in AP & ROW Countries

3. SPECIALTY PERIPHERAL VASCULAR PRODUCTS

  • 3.1. Atherectomy Technologies
  • 3.2. Balloon Catheters
  • 3.3. Chronic Total Occlusion Devices
  • 3.4. Embolic Protection Systems
  • Exhibit 3-1: Specialty Peripheral Vascular Products by Type
  • Exhibit 3-2: Selected Recent Studies of Atherectomy for Peripheral Artery Disease
  • Exhibit 3-3: Atherectomy Devices: Selected Products and Suppliers in 2014
  • Exhibit 3-4: Selected Recent Studies of Balloon Angioplasty for Peripheral Artery Disease
  • Exhibit 3-5: Balloon Catheters: Selected Products and Suppliers in 2014
  • Exhibit 3-6: Selected Recent Studies of Devices Used for Peripheral Artery Chronic Total Occlusion
  • Exhibit 3-7: Devices for Chronic Total Occlusion: Selected Products and Suppliers in 2014
  • Exhibit 3-8: Selected Recent Studies of Devices Used for Embolic Protection during Peripheral Artery Procedures
  • Exhibit 3-9: Embolic Protection Devices: Selected Products and Suppliers in 2014

4. PROCEDURE FORECASTS & MARKET ANALYSIS FOR SPECIALTY PERIPHERAL VASCULAR PRODUCTS IN THE U.S.

  • 4.1. Atherectomy Products
  • 4.2. Balloon Catheters
  • 4.3. Chronic Total Occlusion Devices
  • 4.4. Embolic Protection Devices
  • 4.5. Competitive Analysis
  • Exhibit 4-1: The U.S. Market Forecast for Specialty Peripheral Vascular Products by Type, 2012-2019
  • Exhibit 4-2: The U.S. Market Forecast for Atherectomy Products from 2012-2019
  • Exhibit 4-3: The U.S. Market Forecast for Atherectomy Devices by Type in 2012, 2013, and 2014
  • Exhibit 4-4: The U.S. Market Forecast for Balloon Catheters from 2012-2019
  • Exhibit 4-5: The U.S. Market Forecast for Balloon Catheters by Type from 2012-2019
  • Exhibit 4-6: The U.S. Market Forecast for Chronic Total Occlusion Devices from 2012-2019
  • Exhibit 4-7: The U.S. Market Forecast for Embolic Protection Devices from 2012-2019
  • Exhibit 4-8: The U.S. Market Forecast for Embolic Protection Devices by Type from 2012-2019
  • Exhibit 4-9: U.S. Supplier Shares in 2012 and 2013

5. COMPANY PROFILES

  • 5.1. Abbott Vascular (Abbott)
  • 5.2. Bard Peripheral Vascular (C.R. Bard)
  • 5.3. Boston Scientific
  • 5.4. Cook Medical (Cook Group)
  • 5.5. Cordis Corporation (Johnson & Johnson)
  • 5.6. Covidien
  • 5.7. Medtronic
  • 5.8. W.L. Gore and Associates
Back to Top